Rigel Pharmaceuticals Inc (NAS:RIGL)
$ 0.9694 0.0219 (2.31%) Market Cap: 170.04 Mil Enterprise Value: 177.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 80/100

Q4 2018 Rigel Pharmaceuticals Inc Earnings Call Transcript

Feb 28, 2019 / 10:00PM GMT
Release Date Price: $2.19 (-3.10%)
Operator

Good afternoon, and welcome to Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Year-end of 2018. (Operator Instructions) I would like to remind you that this call is being recorded for replay purposes on Rigel's website. (Operator Instructions)

And now I would like to turn the conference over to our first speaker, Dolly Vance, who is Rigel's Executive Vice President, Corporate Affairs and General Counsel.

Dolly A. Vance
Rigel Pharmaceuticals, Inc. - Executive VP of Corporate Affairs, General Counsel & Corporate Secretary

Welcome to our financial results and business update conference call. The financial press release for the fourth quarter and full year of 2018 was issued a short while ago and can be viewed, along with the accompanying slides for this presentation, in the news and events section of our Investor Relations page on our website, www.rigel.com. As a reminder, during today's call, we may make forward-looking statements regarding our financial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot